Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis
- PMID: 24062613
- PMCID: PMC3770070
- DOI: 10.1155/2013/913135
Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis
Abstract
Background: High-producer TGFβ1 genotypes are associated with severe lung disease in cystic fibrosis (CF), but studies combining IL-8, TNFα-, and TGFβ1(+genotype) levels and their impact on CF lung disease are scarce.
Aim: Assessing the relationship between TGF β 1, IL-8, and TNF- α and lung disease in CF in an exacerbation-free interval.
Methods: Twenty four patients delta F508 homozygous (median age 20.5 y, Shwachman score 75, FEV1(%) 83) and 8 controls (median age 27.5 y) were examined. TGF β 1 was assessed in serum and induced sputum (IS) by ELISA, for IL-8 and TNF- α by chemiluminescence in IS and whole blood. Genotyping was performed for TGF β 1 C-509T and T+869C utilizing RFLP.
Results: TGF β 1 in IS (CF/controls median 76.5/59.1 pg/mL, P < 0.074) was higher in CF. There was a negative correlation between TGF β 1 in serum and lung function (LF) (FEV1 (r = -0.488, P = 0.025), MEF 25 (r = -0.425, P = 0.055), and VC (r = -0.572, P = 0.007)). Genotypes had no impact on TGF β 1 in IS, serum, and LF. In IS TGF β 1 correlated with IL-8 (r = 0.593, P < 0.007) and TNF- α (r = 0.536, P < 0.018) in patients colonized by bacteria with flagellin.
Conclusion: TGF β 1 in serum not in IS correlates with LF. In patients colonized by bacteria with flagellin, TGF β 1 correlates with IL-8 and TNF- α in IS.
Figures





Similar articles
-
The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis.BMC Pulm Med. 2022 May 7;22(1):183. doi: 10.1186/s12890-022-01977-1. BMC Pulm Med. 2022. PMID: 35525938 Free PMC article.
-
Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.Lung. 2020 Apr;198(2):377-383. doi: 10.1007/s00408-020-00320-x. Epub 2020 Jan 9. Lung. 2020. PMID: 31919585
-
Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis.BMC Med Genet. 2013 Jul 1;14:66. doi: 10.1186/1471-2350-14-66. BMC Med Genet. 2013. PMID: 23815594 Free PMC article.
-
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.Pediatr Pulmonol. 2011 Jul;46(7):688-95. doi: 10.1002/ppul.21430. Epub 2011 Feb 18. Pediatr Pulmonol. 2011. PMID: 21337732 Free PMC article.
-
Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis.Eur Cytokine Netw. 2007 Mar;18(1):31-7. doi: 10.1684/ecn.2007.0084. Epub 2007 Mar 30. Eur Cytokine Netw. 2007. PMID: 17400536
Cited by
-
The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis.BMC Pulm Med. 2022 May 7;22(1):183. doi: 10.1186/s12890-022-01977-1. BMC Pulm Med. 2022. PMID: 35525938 Free PMC article.
-
Transforming Growth Factor-β1 Selectively Recruits microRNAs to the RNA-Induced Silencing Complex and Degrades CFTR mRNA under Permissive Conditions in Human Bronchial Epithelial Cells.Int J Mol Sci. 2019 Oct 5;20(19):4933. doi: 10.3390/ijms20194933. Int J Mol Sci. 2019. PMID: 31590401 Free PMC article.
-
Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis.Front Genet. 2020 Oct 28;11:570403. doi: 10.3389/fgene.2020.570403. eCollection 2020. Front Genet. 2020. PMID: 33193670 Free PMC article.
-
Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.Lung. 2020 Apr;198(2):377-383. doi: 10.1007/s00408-020-00320-x. Epub 2020 Jan 9. Lung. 2020. PMID: 31919585
-
Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?Int J Mol Sci. 2023 Aug 3;24(15):12412. doi: 10.3390/ijms241512412. Int J Mol Sci. 2023. PMID: 37569787 Free PMC article. Review.
References
-
- Arkwright PD, Pravica V, Geraghty PJ, et al. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. The American Journal of Respiratory and Critical Care Medicine. 2003;167(3):384–389. - PubMed
-
- Drumm ML, Konstan MW, Schluchter MD, et al. Genetic modifiers of lung disease in cystic fibrosis. The New England Journal of Medicine. 2005;353(14):1443–1453. - PubMed
-
- Corvol H, Boelle P, Brouard J, et al. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatric Pulmonology. 2008;43(12):1224–1232. - PubMed
-
- Epstein FH. Role of transforming growth factor β in human disease. The New England Journal of Medicine. 2000;342(18):1350–1358. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous